BioCryst Pharmaceuticals: Q2 Earnings Insights

 

BioCryst Pharmaceuticals BCRX reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

BioCryst Pharmaceuticals beat estimated earnings by 5.88%, reporting an EPS of $-0.32 versus an estimate of $-0.34.

Revenue was up $15.57 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 7.06% drop in the share price the next day.

Here's a look at BioCryst Pharmaceuticals's past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.37 -0.3 -0.29 -0.24
EPS Actual -0.40 -0.4 -0.33 -0.24
Revenue Estimate 51.36M 50.56M 39.38M 28.48M
Revenue Actual 49.92M 47.16M 40.99M 49.96M

To track all earnings releases for BioCryst Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!